HUMORAL ANTIBODIES AND RESISTANCE OF VACCINATED AND CONVALESCENT MONKEYS TO POLIOMYELITIS VIRUS

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Poliomyelitis is a serious infectious disease.
• Understanding immune responses to poliovirus is crucial for developing effective vaccines and treatments.
• The role of humoral antibodies in polio infection resistance requires further clarification.

Purpose of the Study:

• To investigate the timeline of humoral antibody development in monkeys after paralytic poliomyelitis.
• To compare the resistance to reinfection in convalescent monkeys with that of vaccinated monkeys.
• To determine the significance of humoral antibodies in conferring resistance against poliovirus infection.

Main Methods:

• Monkeys were experimentally infected with poliovirus.
• Paralytic poliomyelitis was induced.
• Humoral antibody levels were monitored over time using serum samples.
• Resistance to reinfection was assessed via nasal route challenge with the same poliovirus strain.

Main Results:

• Convalescent monkeys developed humoral antibodies slowly, with antibodies appearing 2-3 months post-infection.
• Monkeys resistant to reinfection showed resistance before detectable antibodies in their serum.
• Vaccinated monkeys with neutralizing antibodies in serum remained susceptible to nasal infection.
• Antibody titers in resistant convalescent monkeys were not quantitatively higher than in susceptible vaccinated monkeys.

Conclusions:

• Humoral antibody development is slow in monkeys recovering from paralytic poliomyelitis.
• Resistance to poliovirus reinfection can occur independently of detectable circulating antibodies.
• Humoral antibodies play a different role in mediating resistance to infection in naturally infected (convalescent) versus vaccinated monkeys.